Supplementary materials and methods
separately for males and females and appended the two sets of datasets together to allow us to assess interactions in the multiple imputation datasets. The multiple multivariate imputation approach creates a specified number of copies of the data (in our case, 20 copies) in which missing values are imputed by chained equations, with an appropriate level of randomness. The main results presented in this paper on the multiple imputation datasets are obtained by averaging the results from each of these 20 datasets using Rubin's rules. In this procedure, the standard errors for any regression coefficients (used to calculate p-values and 95% confidence intervals) take account of the uncertainty in the imputations as well as uncertainty in the estimate. The analyses based on these multivariate imputations all include data from the 1827 eligible participants in the USS dataset and the 3106 participants in the biomarker dataset. We also repeated analyses including only those participants with complete data on all variables used in our analyses, i.e., with no missing data (n = 1281 for the USS dataset and n = 2467 for the biomarker dataset). Results from the complete case analyses were very similar to those found based on the multiple imputation datasets. Multiple imputation results are presented in Supplementary Tables 3 and 4 below. Complete case analysis results are available on request.
Additional analyses
To verify the MAR assumption of the multilevel models and assess potential bias caused by missing data, analyses including the weight trajectories as exposures were repeated after restricting to participants with (i) at least two measures of weight and length/height from birth to 10 years (n = 1822 in the USS dataset and n = 3075 in the blood-based liver outcomes dataset) and (ii) at least one measure of weight and length/height in each of the age periods defined by our linear-splines (n = 1249 in the USS dataset and n = 2093 in the blood-based liver outcomes dataset). Analyses were also repeated for participants with complete data for all variables included in the analysis (i.e., with no missing data). In additional analyses, we adjusted for AUDIT scores (in addition to removing those with persistent high scores over the year prior to the 17-18y follow-up). AUDIT scores from the time of the outcome assessments (mean age 17.8y) were used if available (80% and 83% of eligible participants in the USS and bloodbased liver outcomes datasets, respectively). AUDIT scores assessed in the previous year (mean age 16.7y) were used if the score from the time of the outcome assessments was not available (11% and 10% of eligible participants in the USS and blood-based liver outcomes datasets, respectively). The remaining 9% and 7% of AUDIT scores for eligible participants in the USS and blood-based liver outcomes datasets, respectively, were imputed as described above. As BMI in infants under age 2 years may not be a useful measure of adiposity, analyses were repeated using Ponderal Index as the exposure, instead of BMI. Additional analyses were not repeated for associations of infant and childhood BMI with the liver outcomes, as BMI variables were derived from the height and weight trajectories. We tested for evidence of an interaction with birth weight by including a binary interaction term in all regression models, comparing participants in the lowest tertile of birth weight to those in the upper two tertiles of birth weight. SD, standard deviation. *In additional analyses on the USS imputed dataset, AUDIT scores were adjusted for. AUDIT scores from the time of the outcome assessments (at mean age 17.8y) were used if available (80% of eligible participants in the USS dataset). AUDIT scores assessed in the previous year (mean age 16.7y) were used if the score from the time of the outcome assessments was not available (11% of eligible participants in the USS dataset). The remaining 9% of AUDIT scores for eligible participants in the USS dataset were imputed. SD, standard deviation. *AUDIT scores from the time of the outcome assessments (at mean age 17.8y) were used if available (83% of eligible participants in the biomarker dataset). AUDIT scores assessed in the previous year (mean age 16.7y) were used if the score from the time of the outcome assessments was not available (10% of eligible participants in the biomarker dataset). The remaining 7% of AUDIT scores for eligible participants in the biomarker dataset were imputed. The SDs for birth weight and the weight change periods are as follows: birth weight = 0.48kg; weight-for-height gain 0-3 months = 0.19kg/month; weight-for-height gain 3 months-1 year = 0.09kg/month; weight-for-height gain 1-3 years = 0.03kg/month; weight-for-height gain 3-7 years = 0.05kg/month; weight-for-height gain from 7-10 years = 0.11kg/month. Model 1 is unadjusted. Model 2 adjusts for length or length/height change in the same period as the weight or weight change exposure. Model 3 is additionally adjusted for age of the study child at the outcome assessment and potential confounding by gender, gestational age, breastfeeding at age 3 months, parity, maternal age at the birth of the study child, maternal prepregnancy smoking status and alcohol consumption and household social class. Breastfeeding is not adjusted for when birth weight is the exposure variable. Table 3 . Associations of weight-for-height change from birth to 120 months with ALT and AST in the imputed dataset of eligible participants with biomarker data (n = 3106). Coefficients are per 1 standard deviation (SD) increase in weight at age 3 months or per SD increase in the rate of weight change in each age period defined by the linear spline model. The SDs for birth weight and the weight change periods are as follows: birth weight = 0.49kg; weight-for-height gain 0-3 months = 0.49kg/month; weight-for-height gain 3 months-1 year = 0.09kg/month; weight-for-height gain 1-3 years = 0.03kg/month; weight-for-height gain 3-7 years = 0.05kg/month; weight-for-height gain from 7-10 years = 0.10kg/month. Model 1 is unadjusted. Model 2 adjusts for length or length/height change in the same period as the weight or weight change exposure. Model 3 is additionally adjusted for age of the study child at the outcome assessment and potential confounding by gender, gestational age, breastfeeding at age 3 months, parity, maternal age at the birth of the study child, maternal pre-pregnancy smoking status and alcohol consumption and household social class. Breastfeeding is not adjusted for when birth weight is the exposure variable.
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